title: Manganese superoxide dismutase polymorphism, treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer.
authors.affiliation: Department of Cancer and Prevention and Control, Roswell Park Cancer Institute, Elm & Carlton Sts, Buffalo, NY 14263, USA. Song.Yao@roswellpark.org
authors.forename: Song
authors.initials: S
authors.lastname: Yao
authors.forename: William E
authors.initials: WE
authors.lastname: Barlow
authors.forename: Kathy S
authors.initials: KS
authors.lastname: Albain
authors.forename: Ji-Yeob
authors.initials: JY
authors.lastname: Choi
authors.forename: Hua
authors.initials: H
authors.lastname: Zhao
authors.forename: Robert B
authors.initials: RB
authors.lastname: Livingston
authors.forename: Warren
authors.initials: W
authors.lastname: Davis
authors.forename: James M
authors.initials: JM
authors.lastname: Rae
authors.forename: I-Tien
authors.initials: IT
authors.lastname: Yeh
authors.forename: Laura F
authors.initials: LF
authors.lastname: Hutchins
authors.forename: Peter M
authors.initials: PM
authors.lastname: Ravdin
authors.forename: Silvana
authors.initials: S
authors.lastname: Martino
authors.forename: Alan P
authors.initials: AP
authors.lastname: Lyss
authors.forename: C Kent
authors.initials: CK
authors.lastname: Osborne
authors.forename: Martin D
authors.initials: MD
authors.lastname: Abeloff
authors.forename: Gabriel N
authors.initials: GN
authors.lastname: Hortobagyi
authors.forename: Daniel F
authors.initials: DF
authors.lastname: Hayes
authors.forename: Christine B
authors.initials: CB
authors.lastname: Ambrosone
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics* / Q000401:mortality; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006801:Humans; D016015:Logistic Models; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced / Q000201:enzymology / Q000235:genetics; D016017:Odds Ratio; D010641:Phenotype; D011110:Polymorphism, Genetic; D011446:Prospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D015206:Southwestern United States; D013482:Superoxide Dismutase / Q000235:genetics* / Q000378:metabolism; D013629:Tamoxifen / Q000008:administration & dosage; D013997:Time Factors; D016896:Treatment Outcome; D000099156:Superoxide Dismutase 2
chemical_list: D003520:Cyclophosphamide; D004317:Doxorubicin; D005472:Fluorouracil; D008727:Methotrexate; D013482:Superoxide Dismutase; D013629:Tamoxifen; D000099156:Superoxide Dismutase 2